As more and more academic institutions are imposing a blanket policy ban of commercial/ pharmaceutical support for CME activities, this study suggests that we should first look at the complexities behind hosting a CME conference before taking such sweeping actions. This study takes a fascinating first step in making the true operational costs and clinician perceptions transparent.
Reference Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Arch Intern Med. 2011; 171(9), 840-6. PMID: 21555662 |
Write a comment:
|

In an interesting survey-based publication by Dr. Tabas (one of my colleagues) that just came out in Archives of Internal Medicine, we learn more about the ins and outs of CME activities. The authors set out to determine the audience members' opinions about